Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease
Clémence Martin, Espérie Burnet, A. Ronayette-Preira, P. De Carli, J A Portillo Martín, L. Delmas, Béatrice Prieur, Pierre‐Régis Burgel
Topics & Concepts
IvacaftorMedicineCystic fibrosisQuality of life (healthcare)DiseaseInternal medicineCystic fibrosis transmembrane conductance regulatorNursingCystic Fibrosis Research AdvancesPediatric health and respiratory diseasesAsthma and respiratory diseases